SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-09-001133
Filing Date
2009-09-08
Accepted
2009-09-08 09:31:31
Documents
7
Period of Report
2009-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k.htm 6-K 14015
2 ANNUAL REPORT FOR THE PERIOD ENDED MAY 31, 2009 ex991.htm EX-99.1 1317677
3 GRAPHIC kpmg.jpg GRAPHIC 9755
4 GRAPHIC sig.jpg GRAPHIC 2961
5 GRAPHIC loruslogo.jpg GRAPHIC 36672
6 GRAPHIC ayoungsig.jpg GRAPHIC 4081
7 GRAPHIC ewilliamssig.jpg GRAPHIC 4702
  Complete submission text file 0001279569-09-001133.txt   1414161
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 091057196
SIC: 2836 Biological Products, (No Diagnostic Substances)